Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol Review
  • Published:

A Word from OLAW

This is a preview of subscription content, access via your institution

Access options

References

  1. Office of Extramural Research, National Institutes of Health. NIH Grants Policy Statement, Part II, Terms and Conditions of Grant Awards, Part A, Section 4.1.1.3, Consortiums. (US Department of Health and Human Services, Bethesda, MD, USA, revised December 2019). https://grants.nih.gov/grants/policy/nihgps/html5/section_4/4.1.1_animal_welfare_requirements.htm#Consorti (accessed, November 16, 2020).

  2. Office of Extramural Research, National Institutes of Health. NIH Grants Policy Statement, Part II, Terms and Conditions of Grant Awards, Part B, 15.2.1, Written Agreement. (US Department of Health and Human Services, Bethesda, MD, USA, revised December 2019) https://grants.nih.gov/grants/policy/nihgps/html5/section_15/15.2_administrative_and_other_requirements.htm#Written (accessed, November 16, 2020).

  3. Office of Extramural Research, National Institutes of Health. NIH Grants Policy Statement, Part II: Part A, Section 4.1.26, Research Involving Recombinant or Synthetic Nucleic Acid Molecules (including Human Gene Transfer Research). (US Department of Health and Human Services, Bethesda, MD, USA, revised December 2019). https://grants.nih.gov/grants/policy/nihgps/html5/section_4/4.1.26_research_involving_recombinant_or_synthetic_nucleic_acid_molecules__including_human_gene_transfer_research_.htm (accessed, November 16, 2020).

  4. Office of Science Policy, National Institutes of Health. NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. (US Department of Health and Human Services, Bethesda, MD, USA, revised April 2019) https://osp.od.nih.gov/wp-content/uploads/2019_NIH_Guidelines.htm (accessed November 16, 2020).

  5. Office of Science Policy, National Institutes of Health. FAQs – Interim Laboratory Biosafety Guidance for Research with SARS-CoV-2 and IBC Requirements under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules. https://osp.od.nih.gov/biotechnology/interim-lab-biosafety-guidance-for-research-with-sars-cov-2/ (accessed November 16, 2020).

  6. National Institutes of Health. Public Health Service Policy on Humane Care and Use of Laboratory Animals – Frequently Asked Questions. Protocol Review, Question D.8. (US Department of Health and Human Services, Bethesda, MD, USA, revised 2017) https://olaw.nih.gov/guidance/faqs#621 (accessed November 16, 2020).

  7. Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. 8th edition, p 15, (National Academies Press, Washington, D.C., USA, 2011).

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patricia Brown VMD, MS, DACLAM.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brown, P. A Word from OLAW. Lab Anim 50, 5 (2021). https://doi.org/10.1038/s41684-020-00690-y

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41684-020-00690-y

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing